Top KPIs

We have some big outlandish goals. And KPIs to match it.

Introduction

The goal to significantly reduce death rates and save lives is a serious and outlandish goal, and we have KPIs to match it. As Haypp Group expands, more people’s lives can be saved by reducing unhealthy tobacco use while at the same time promoting more sustainable products and packaging.

Our KPIs

  • Global deaths by smoking yearly
  • Active Haypp Group customers
  • Lives saved by using Haypp products
  • Percentage of Haypp Group customers that have changed from smoking

Key figures

Global deaths by smoking yearly

WHO 2020

Active Haypp customers

May 2021

Lives saved by using Haypp products

May 2021

Method for calculating

Method for calculating number of lives and years saved

 

The number of lives saved is calculated as:

  • the number of Haypp customers who states they have quit smoking with the help of Haypp’s products,

multiplied with

  • the share of former smokers who will be saved from a smoking-attributable death by quitting smoking.1

This figure is calculated for age-groups <35, 35-54, 55-64, 65-74 and 75+ respectively and then summed up.

 

The number of years saved is calculated as:

  • the number of Haypp customers who states they have quit smoking with the help of Haypp’s products,

multiplied with

  • the expected gain in life expectancy from quitting smoking.2

This figure is calculated for age-groups <35, 35-44, 45-54, and 55-64 respectively and then summed up.

 

Notes and references

1 The share of former smokers saved from a smoking-attributable death by quitting smoking is calculated as:

  • (at least) 50 per cent of smokers die from smoking, Jha (2020)

multiplied with

  • the reduced relative risk of former smokers, compared to smokers, dying in a smoking-attributable death (appr. 71 to 97 per cent depending on age), Jha (2020).

 

2 The gain in life expectancy is taken from Jha (2020).

Jha, Prabhat (2020): The hazards of smoking and the benefits of cessation: A critical summation of the epileptological evidence in high-income countries. eLife 2020;9:e49979.